what are the different types of glp-1 drugs List Receptor Agonists for Diabetes & Weight Loss Lesson: Oral Semaglutide: A New

Virili C, Antonelli A, Santaguida MG, Benvenga S, Centanni M

GIP/GLP-1 Dual Agonists The research shows that tirzepatide outperforms semaglutide at both weight loss and blood sugar control

Tirzepatide as a novel effective and safe strategy for treating obesity: a systematic review and meta-analysis of randomized controlled trials

Discussion In this retrospective cohort study, both treatment persistence and adherence were assessed among GLP-1RA users and other glucose-lowering treatment groups

Admittedly, these metabolic analyses were focused on the initial phase of treatments, as this period displayed the largest changes in body weight and is less likely affected by compensatory responses, which might confound the identification of primary mechanisms

Eli Lilly - Manufacturing Investment (February 2026): Eli Lilly reported $1.5 billion pre-launch inventory for orforglipron and announced new manufacturing facilities as part of $27 billion investment drive [4]